What type of multiple sclerosis is Gilenya (fingolimod hydrochloride) indicated to treat in adults and children aged 10 years and older?

Gilenya (fingolimod hydrochloride) is sole disease-modifying therapy for highly active relapsing-remitting MS in adults and children ≥10 years despite full, adequate treatment with ≥1 disease-modifying therapy, or rapidly evolving severe MS (≥2 disabling relapses/year with ≥1 gadolinium-enhancing brain MRI lesion or significantly increased T2 lesion load versus recent MRI).